• Laura M Perry, Oliver Sartor, Sonia Malhotra, Sarah Alonzi, Seowoo Kim, Hallie M Voss, James L Rogers, William Robinson, Kendra Harris, Jessica Shank, David G Morrison, Ashley B Lewson, Jyotsna Fuloria, Lucio Miele, Brian Lewis, Brenna Mossman, and Michael Hoerger.
• Tulane University, New Orleans, Louisiana, USA.
• J Pain Symptom Manage. 2021 Nov 1; 62 (5): 987996987-996.

ContextEarly integrated palliative care improves quality of life, but palliative care programs are underutilized. Psychoeducational interventions explaining palliative care may increase patients' readiness for palliative care.ObjectivesTo 1) collaborate with stakeholders to develop the EMPOWER 2 intervention explaining palliative care, 2) examine acceptability, 3) evaluate feasibility and preliminary efficacy.MethodsThe research was conducted at a North American cancer center and involved 21 stakeholders and 10 patient-participants. Investigators and stakeholders iteratively developed the intervention. Stakeholders rated acceptability of the final intervention. Investigators implemented a pre-post trial to examine the feasibility of recruiting 10 patients with metastatic cancer within one month and with a ≥50% consent rate. Preliminary efficacy outcomes were changes in palliative care knowledge and attitudes.ResultsUsing feedback from four stakeholder meetings, we developed a multimedia intervention tailored to three levels of health-literacy. The intervention provides knowledge and reassurance about the purpose and nature of palliative care, addressing cognitive and emotional barriers to utilization. Stakeholders rated the intervention and design process highly acceptable (3.78/4.00). The pilot met a priori feasibility criteria (10 patients enrolled in 14 days; 83.3% consent rate). The intervention increased palliative care knowledge by 83.1% and improved attitudes by 18.9 points on a 0 to 51 scale (Ps < 0.00001).ConclusionsThis formative research outlines the development of a psychoeducational intervention about palliative care. The intervention is acceptable, feasible, and demonstrated promising pilot test results. This study will guide clinical teams in improving patients' readiness for palliative care and inform the forthcoming EMPOWER 3 randomized clinical trial.Copyright © 2021 American Academy of Hospice and Palliative Medicine. All rights reserved.

13 keywords...

hide…